Measuring Emotional Awareness in Patients With Schizophrenia and Schizoaffective Disorders

被引:3
|
作者
Maassen, Eva [1 ,2 ,3 ]
Buettner, Marielle [1 ,2 ,3 ]
Broecker, Anna-Lena [1 ,2 ,3 ]
Stuke, Frauke [1 ,2 ,3 ]
Bayer, Samuel [1 ,2 ,3 ,4 ]
Hadzibegovic, Jasmina [1 ,2 ,3 ]
Just, Sandra Anna [1 ,2 ,3 ]
Bertram, Gianna [1 ,2 ,3 ]
Rau, Richard [5 ]
von Haebler, Dorothea [1 ,2 ,3 ,4 ]
Lempa, Guenter [6 ]
Montag, Christiane [1 ,2 ,3 ]
机构
[1] Charite Univ Med Berlin, Dept Psychiat & Psychotherapy, Psychiat Univ Clin, St Hedwig Hosp, Berlin, Germany
[2] Humboldt Univ, Freie Univ Berlin, Berlin, Germany
[3] Berlin Inst Hlth, Berlin, Germany
[4] Psychoanalyt Univ Berlin, Berlin, Germany
[5] Univ Munster, Dept Psychol, Munster, Germany
[6] Psychotherapy Practice, Munich, Germany
来源
FRONTIERS IN PSYCHOLOGY | 2021年 / 12卷
关键词
schizophrenia; emotional awareness; affective mentalizing; theory of mind; levels of emotional awareness scale; METACOGNITION ASSESSMENT SCALE; NEGATIVE-SYNDROME-SCALE; SOCIAL COGNITION; MIND; ASSOCIATIONS; DEFICITS; RECOGNITION; ALEXITHYMIA; EMPATHY; SELF;
D O I
10.3389/fpsyg.2021.725787
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
The ability to mentalize (i.e., to form representations of mental states and processes of oneself and others) is often impaired in people with schizophrenia spectrum disorders. Emotional awareness (EA) represents one aspect of affective mentalizing and can be assessed with the Levels of Emotional Awareness Scale (LEAS), but findings regarding individuals with schizophrenia spectrum disorders are inconsistent. The present study aimed at examining the usability and convergent validity of the LEAS in a sample of N = 130 stabilized outpatients with schizophrenia or schizoaffective disorders. An adequacy rating was added to the conventional LEAS rating to account for distortions of content due to, for example, delusional thinking. Scores of the patient group were compared with those of a matched healthy control sample. Correlation with symptom clusters, a self-report measure of EA, a measure of synthetic metacognition (MAS-A-G), and an expert rating capturing EA from the psychodynamic perspective of psychic structure (OPD-LSIA) were examined. Regarding self-related emotional awareness, patients did not score lower than controls neither in terms of conventional LEAS nor in terms of adequacy. Regarding other-related emotional awareness, however, patients showed a reduced level of adequacy compared to controls whereas no such difference was found for conventional LEAS scores. Higher conventional LEAS scores were associated with fewer negative symptoms, and higher structural integration of self-perceptions measured by the OPD-LSIA. Higher adequacy of responses correlated with fewer symptoms of disorganization as well as excitement, higher scores of self-reflection on the MAS-A-G as well as self- and object-perception and internal and external communication as measured by the subscales of the OPD-LSIA. Findings suggest that the LEAS might not be sensitive enough to detect differences between mildly symptomatic patients with schizophrenia or schizoaffective disorders and healthy controls. However, LEAS ratings are still suitable to track intraindividual changes in EA over time. Observing the adequacy of patients' responses when using the LEAS may be a promising way to increase diagnostical utility and to identify patterns of formal and content-related alterations of mentalizing in this patient group. Methodological indications for future studies are discussed.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Emotional awareness and delusions in schizophrenia and schizoaffective disorder
    D'Antonio, Emily
    Kahn, Jennifer
    McKelvey, Jennifer
    Berenbaum, Howard
    Serper, Mark R.
    [J]. COMPREHENSIVE PSYCHIATRY, 2015, 57 : 106 - 111
  • [2] AWARENESS OF ILLNESS IN SCHIZOPHRENIA AND SCHIZOAFFECTIVE AND MOOD DISORDERS
    AMADOR, XF
    FLAUM, M
    ANDREASEN, NC
    STRAUSS, DH
    YALE, SA
    CLARK, SC
    GORMAN, JM
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 1994, 51 (10) : 826 - 836
  • [3] Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders
    Cohen, D
    Stolk, RP
    Grobbee, DE
    Gispen-De Wied, CC
    [J]. DIABETES CARE, 2006, 29 (04) : 786 - 791
  • [4] Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders
    Cohen, Dan
    [J]. DIABETES CARE, 2007, 30 (02) : 447 - 448
  • [5] Voxel-based Morphometry of Patients with Schizophrenia and Schizoaffective Disorders
    Shafferi, Johnathon
    Choupan, Jeiran
    Mowry, Bryan
    Yang, Zhengyi
    Reutens, David
    [J]. NEUROLOGY, 2016, 86
  • [6] VOXEL-BASED MORPHOMETRY OF PATIENTS WITH SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDERS
    Shaffer, J.
    Choupan, J.
    Mowry, B.
    Yang, Z.
    Reutens, D.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2015, 63 (02) : 443 - 443
  • [7] Schizophrenia and Schizoaffective are Psychotic Mood Disorders
    Aires, Daniel J.
    Hurwitz, Nathaniel G.
    [J]. PSYCHIATRIC ANNALS, 2010, 40 (02) : 98 - 102
  • [9] Is it true remission? A study of remitted patients affected by schizophrenia and schizoaffective disorders
    Pinna, Federica
    Deriu, Luca
    Lepori, Tiziana
    Maccioni, Raffaela
    Milia, Paola
    Sarritzu, Elisabetta
    Tusconi, Massimo
    Carpiniello, Bernardo
    [J]. PSYCHIATRY RESEARCH, 2013, 210 (03) : 739 - 744
  • [10] Olanzapine in the treatment of agitation in hospitalized patients with schizophrenia and schizoaffective and schizofreniform disorders
    Turczynski, J
    Bidzan, L
    Staszewska-Malys, E
    [J]. MEDICAL SCIENCE MONITOR, 2004, 10 (05): : PI74 - PI80